We provide you with 20 years of free, institutional-grade data for RGLS stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of RGLS. Explore the full financial landscape of RGLS stock.
| Reported Date | CIK | Ticker | Type |
|---|
Regulus Therapeutics Inc(NASDAQ:RGLS) 
Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that target microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in clinical trial for the trea...
Website: http://www.regulusrx.com
Founded: 2007
Full Time Employees: 24
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about RGLS stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.